Drugs

Drugs in patients on dialysis to improve nutritional status

Can pharmacologic interventions be used in patients on dialysis to improve nutritional status? Pharmacologic measures to improve nutrition include appetite stimulators (megestrol acetate) or interventions to improve biochemical measures of PEW, such as the use of anabolic hormones. These interventions have been tested in small clinical trials, but their use in clinical practice remains uncommon, …

Drugs in patients on dialysis to improve nutritional status Read More »

Hypoxia inducible factor prolyl hydroxylase inhibitors

What are hypoxia inducible factor prolyl hydroxylase inhibitors? Several agents are under development that potentiate the activity of HIF, the substance in the kidney and other tissues that senses decreased delivery of oxygen (from hypoxemia or anemia) and stimulates the production of EPO. In the absence of hypoxia, HIF is rapidly degraded by an enzyme, …

Hypoxia inducible factor prolyl hydroxylase inhibitors Read More »

Biosimilars

What are biosimilars? Since Erythropoiesis Stimulating Agents are complex proteins with side chains, not every molecule is identical to each other, and therefore it is impossible to develop a “generic” version that is identical to the originator molecule. For biologic drugs whose patents have expired, the FDA has developed an approval pathway for biosimilar agents …

Biosimilars Read More »

What drugs must be avoided in Chronic kidney disease

What drugs must be avoided in Chronic kidney disease? Whenever possible, nephrotoxic medications should be avoided including NSAIDs, which should be stopped when eGFR is <30 mL/min per 1.73m 2 and not prescribed long-term in patients with eGFR <60 mL/min per 1.73m 2 . Other nephrotoxic medications are aminoglycosides, amphotericin, and cisplatin. The GFR level needs to be considered …

What drugs must be avoided in Chronic kidney disease Read More »

Side effects of medications on Kidneys

Side effects of medications on Kidneys • Hypertension and proteinuria are the most common adverse effects on the kidneys of the antiangiogenesis inhibitors (bevacizumab, sorafenib, sunitinib), which target the vascular endothelial growth factor signaling pathway. • The proton pump inhibitors are associated primarily with acute interstitial nephritis (AIN); however, less common adverse effects involving the kidneys include …

Side effects of medications on Kidneys Read More »

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856